Cardiovascular and Metabolic Disease: New Treatment and Future Directions
The present Special Issue will lead you to discover the association between cardiovascular and metabolic diseases, through update reviews and original articles exploring the pathophysiological mechanisms underpinning this association and describing the latest results in term of cardiovascular event...
Spremljeno u:
| Format: | Online |
|---|---|
| Jezik: | engleski |
| Izdano: |
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Teme: | |
| Online pristup: | ONIX_20230714_9783036578798_16 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
| _version_ | 1869516414536122368 |
|---|---|
| collection | Directory of Open Access Books |
| description | The present Special Issue will lead you to discover the association between cardiovascular and metabolic diseases, through update reviews and original articles exploring the pathophysiological mechanisms underpinning this association and describing the latest results in term of cardiovascular event prevention. An interesting scientific journey that reflects the recent advances in pharmacological treatments and interventional procedures. |
| format | Online |
| id | doab-20.500.12854ir-101317 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2023 |
| publishDateRange | 2023 |
| publishDateSort | 2023 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1013172024-03-31T13:08:09Z Cardiovascular and Metabolic Disease: New Treatment and Future Directions Caturano, Alfredo Galiero, Raffaele low-density lipoprotein receptor apolipoprotein E hyperglycemia type 2 diabetes Western diet diabetes mellitus GPCRs GPR26 monocytes peripheral blood cells metabolomics diabetes N-Acetyl asparagine QTc cardiac fibrosis scar tissue anti-fibrotic therapies cardiovascular diseases myofibroblasts nitric oxide synthase uncoupling sapropterin diabetic nephropathy atrial fibrillation hyperthyroidism warfarin ischemic stroke transient ischemic attack transplant complications mortality outcome glucose metabolism body mass index metabolic syndrome breast arterial calcifications cardiovascular risk mammograms risk assessment prevention cost effectiveness cardiac autonomic neuropathy oxidative stress inflammation endothelium dysfunction direct oral anticoagulant stroke prevention elderly frail malignancy extreme weight bioprosthetic valve endocannabinoid system CB1 cannabinoid receptor metabolic disease non-alcoholic fatty liver disease sodium-glucose cotransporter inhibitors metformin FibroScan® controlled attenuation parameter type 2 diabetes mellitus heart failure hemodynamics dapagliflosin adropin natriuretic peptide thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology The present Special Issue will lead you to discover the association between cardiovascular and metabolic diseases, through update reviews and original articles exploring the pathophysiological mechanisms underpinning this association and describing the latest results in term of cardiovascular event prevention. An interesting scientific journey that reflects the recent advances in pharmacological treatments and interventional procedures. 2023-07-14T14:23:47Z 2023-07-14T14:23:47Z 2023 book ONIX_20230714_9783036578798_16 9783036578798 9783036578781 https://directory.doabooks.org/handle/20.500.12854/101317 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/7411 https://mdpi.com/books/pdfview/book/7411 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-7878-1 10.3390/books978-3-0365-7878-1 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036578798 9783036578781 210 Basel open access |
| spellingShingle | low-density lipoprotein receptor apolipoprotein E hyperglycemia type 2 diabetes Western diet diabetes mellitus GPCRs GPR26 monocytes peripheral blood cells metabolomics diabetes N-Acetyl asparagine QTc cardiac fibrosis scar tissue anti-fibrotic therapies cardiovascular diseases myofibroblasts nitric oxide synthase uncoupling sapropterin diabetic nephropathy atrial fibrillation hyperthyroidism warfarin ischemic stroke transient ischemic attack transplant complications mortality outcome glucose metabolism body mass index metabolic syndrome breast arterial calcifications cardiovascular risk mammograms risk assessment prevention cost effectiveness cardiac autonomic neuropathy oxidative stress inflammation endothelium dysfunction direct oral anticoagulant stroke prevention elderly frail malignancy extreme weight bioprosthetic valve endocannabinoid system CB1 cannabinoid receptor metabolic disease non-alcoholic fatty liver disease sodium-glucose cotransporter inhibitors metformin FibroScan® controlled attenuation parameter type 2 diabetes mellitus heart failure hemodynamics dapagliflosin adropin natriuretic peptide thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology Cardiovascular and Metabolic Disease: New Treatment and Future Directions |
| title | Cardiovascular and Metabolic Disease: New Treatment and Future Directions |
| title_full | Cardiovascular and Metabolic Disease: New Treatment and Future Directions |
| title_fullStr | Cardiovascular and Metabolic Disease: New Treatment and Future Directions |
| title_full_unstemmed | Cardiovascular and Metabolic Disease: New Treatment and Future Directions |
| title_short | Cardiovascular and Metabolic Disease: New Treatment and Future Directions |
| title_sort | cardiovascular and metabolic disease new treatment and future directions |
| topic | low-density lipoprotein receptor apolipoprotein E hyperglycemia type 2 diabetes Western diet diabetes mellitus GPCRs GPR26 monocytes peripheral blood cells metabolomics diabetes N-Acetyl asparagine QTc cardiac fibrosis scar tissue anti-fibrotic therapies cardiovascular diseases myofibroblasts nitric oxide synthase uncoupling sapropterin diabetic nephropathy atrial fibrillation hyperthyroidism warfarin ischemic stroke transient ischemic attack transplant complications mortality outcome glucose metabolism body mass index metabolic syndrome breast arterial calcifications cardiovascular risk mammograms risk assessment prevention cost effectiveness cardiac autonomic neuropathy oxidative stress inflammation endothelium dysfunction direct oral anticoagulant stroke prevention elderly frail malignancy extreme weight bioprosthetic valve endocannabinoid system CB1 cannabinoid receptor metabolic disease non-alcoholic fatty liver disease sodium-glucose cotransporter inhibitors metformin FibroScan® controlled attenuation parameter type 2 diabetes mellitus heart failure hemodynamics dapagliflosin adropin natriuretic peptide thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology |
| topic_facet | low-density lipoprotein receptor apolipoprotein E hyperglycemia type 2 diabetes Western diet diabetes mellitus GPCRs GPR26 monocytes peripheral blood cells metabolomics diabetes N-Acetyl asparagine QTc cardiac fibrosis scar tissue anti-fibrotic therapies cardiovascular diseases myofibroblasts nitric oxide synthase uncoupling sapropterin diabetic nephropathy atrial fibrillation hyperthyroidism warfarin ischemic stroke transient ischemic attack transplant complications mortality outcome glucose metabolism body mass index metabolic syndrome breast arterial calcifications cardiovascular risk mammograms risk assessment prevention cost effectiveness cardiac autonomic neuropathy oxidative stress inflammation endothelium dysfunction direct oral anticoagulant stroke prevention elderly frail malignancy extreme weight bioprosthetic valve endocannabinoid system CB1 cannabinoid receptor metabolic disease non-alcoholic fatty liver disease sodium-glucose cotransporter inhibitors metformin FibroScan® controlled attenuation parameter type 2 diabetes mellitus heart failure hemodynamics dapagliflosin adropin natriuretic peptide thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology |
| url | ONIX_20230714_9783036578798_16 |